|
|
||||||||
Ann Thorac Surg 2002;73:S374
© 2002 The Society of Thoracic Surgeons
* Department of Anesthesia, University Campus LHSC, University of Western Ontario, London, Ontario, Canada
# Bayer Inc, New Haven, Conn, USA
Full dose aprotinin administration has been associated with a significant decrease in perioperative stroke in patients undergoing coronary artery bypass (CABG) surgery. To further assess this observation a meta-analysis of 7 placebo controlled, randomized, double-blind studies of CABG patients receiving full dose aprotinin or placebo was undertaken. [17] The rationale for
This article has been cited by other articles:
![]() |
A. J. Rodrigues, P. R. B. Evora, S. Bassetto, P. M. Luciano, L. Alves Jr, A. S. Filho, and W. V. de Andrade Vicente Efficacy and Safety of Aprotinin Use for Reoperative Valvular Surgery Ann. Thorac. Surg., June 1, 2007; 83(6): 2060 - 2065. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ronald and J. Dunning Does use of aprotinin decrease the incidence of stroke and neurological complications in adult patients undergoing cardiac surgery? Interact CardioVasc Thorac Surg, December 1, 2006; 5(6): 767 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Prasongsukarn and M. A. Borger Reducing Cerebral Emboli During Cardiopulmonary Bypass Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2005; 9(2): 153 - 158. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |